DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Michel MC, Mayoux E, Vallon V.
A comprehensive review of the pharmacodynamics of the SGLT-2 inhibitor empagliflozin in animals and humans.
Naunyn Schmiedebergs Arch Pharmacol 2015;
388: 801-816 . doi:10.1007/s00210-015-1134-1
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.